PDE4DIP and pancreatic adenocarcinoma: To be specific, the high level of PDE4DIP methylation was significantly related to the increase of OS in patients with PAAD, LGG, SKCM, UCEC, and UVM (Figure 4b–f), but only to the decrease of OS in patients with KIRC (Figure 4a).